141 related articles for article (PubMed ID: 9780850)
1. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
Szakáll S; Boros I; Balkay L; Emri M; Fekete I; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Galuska L; Trón L; Bereczki D; Csiba L; Gulyás B
J Neuroimaging; 1998 Oct; 8(4):197-204. PubMed ID: 9780850
[TBL] [Abstract][Full Text] [Related]
2. [The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].
Gulyás B; Bönöczk P; Vas A; Csiba L; Bereczki D; Boros I; Szakáll S; Balkay L; Emri M; Fekete I; Galuska L; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Trón L
Orv Hetil; 2001 Mar; 142(9):443-9. PubMed ID: 11301903
[TBL] [Abstract][Full Text] [Related]
3. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
J Neurol Sci; 2005 Mar; 229-230():275-84. PubMed ID: 15760651
[TBL] [Abstract][Full Text] [Related]
4. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
[TBL] [Abstract][Full Text] [Related]
5. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Valikovics A
Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
[TBL] [Abstract][Full Text] [Related]
7. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136
[TBL] [Abstract][Full Text] [Related]
8. [Human positron emission tomography with oral 11C-vinpocetine].
Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
[TBL] [Abstract][Full Text] [Related]
9. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
Vas A; Sóvágó J; Halldin C; Sandell J; Karlsson P; Kárpáti E; Kiss B; Cselényi Z; Farde L; Gulyás B
Orv Hetil; 2002 Nov; 143(47):2631-6. PubMed ID: 12532649
[TBL] [Abstract][Full Text] [Related]
10. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Bagoly E; Fehér G; Szapáry L
Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
[TBL] [Abstract][Full Text] [Related]
11. [Positron-emission tomography in the diagnosis of middle cerebral artery lesions].
Prakhova LN; Il'ves AG; Kataeva GV; Pozdniakov AV; Stoliarov ID
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):35-40. PubMed ID: 20879103
[TBL] [Abstract][Full Text] [Related]
12. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
[TBL] [Abstract][Full Text] [Related]
13. Can transcranial Doppler really detect reduced cerebral perfusion states?
Sugimori H; Ibayashi S; Fujii K; Sadoshima S; Kuwabara Y; Fujishima M
Stroke; 1995 Nov; 26(11):2053-60. PubMed ID: 7482649
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
15. Determination of regional cerebral blood flow in patients with cerebral infarction. Use of fluoromethane labeled with fluorine 18 and positron emission tomography.
Celesia GG; Polcyn RE; Holden JE; Nickles RJ; Koeppe RA; Gatley SJ
Arch Neurol; 1984 Mar; 41(3):262-7. PubMed ID: 6607723
[TBL] [Abstract][Full Text] [Related]
16. Cerebral glucose metabolism as a predictor of recovery from aphasia in ischemic stroke.
Heiss WD; Kessler J; Karbe H; Fink GR; Pawlik G
Arch Neurol; 1993 Sep; 50(9):958-64. PubMed ID: 8363450
[TBL] [Abstract][Full Text] [Related]
17. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
18. [The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension].
Spirin NN; Pizova NV; Shadrichev VA; Filatov VF; Bakucheva MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):64-6. PubMed ID: 18688926
[No Abstract] [Full Text] [Related]
19. Cerebral blood flow and oxygen metabolism measurements using positron emission tomography on the first day after carotid artery stenting.
Kawai N; Hatakeyama T; Okauchi M; Kawanishi M; Shindo A; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e55-64. PubMed ID: 24119366
[TBL] [Abstract][Full Text] [Related]
20. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
Tamaki N; Matsumoto S
Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
